Short Sellers Run for Cover in Big Pharma
The June 30 short interest data have been compared with the previous figures, and across the selected pharmaceutical stocks, short interest decreased.
The June 30 short interest data have been compared with the previous figures, and across the selected pharmaceutical stocks, short interest decreased.
A new report from UBS highlights three stocks that the firm likes best now. Not only do they all pay a solid dividend and have a good potential for growth, they all…
thinkstockJune 26, 2015: Markets opened higher on Friday but tech stocks almost immediately dragged down the Nasdaq Composite and eventually weighed on the S&P 500 index as well. A weak report from…
The June 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
thinkstockJune 22, 2015: Markets opened higher on Monday as investors appeared optimistic that Greece and the European Central Bank would strike a deal. That hasn’t happened yet today. Gold dropped 1.5% and…
thinkstockJune 12, 2015: Markets opened lower on Friday as a solution to the Greek-European Union seems to draw further away from negotiators. Energy and healthcare stocks both opened weak and were able…
The May 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest is down.
Credit Suisse has updated its autoimmune market model and it sees implications for all of the large cap U.S. pharmaceutical companies in its coverage.
thinkstockJune 2, 2015: Markets opened lower on Tuesday as a settlement of the Greek financial problem continues to evade negotiators. The euro rose today, sending the dollar lower and the yield on…
The short interest data has been released for the May 15 settlement date and for the selected pharmaceutical stocks, short interest is mixed.
thinkstockMay 22 2015: Markets opened mixed on Friday on a day that was tough on blue chips. The energy sector slipped on a stronger dollar and lower crude oil prices, even though…
The April 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
A new research report from Savita Subramanian and her well-regarded team at Merrill Lynch points out that some of the biggest positive surprises have been from the mega-cap stocks.
In a new report, the RBC team focused on the companies that are making the most progress with treatments for patients with breast cancer.
Credit Suisse has released a report that detailed its top picks for pharmaceutical stocks for the rest of 2015.